Table 2.
Comparison of VAS scale before treatment and after 1, 4, and 8 weeks
| Character | GBP (Mean ± SD) | DLX (Mean ± SD) | P-Value | ||
|---|---|---|---|---|---|
| VAS Scale: | |||||
| Pre-treatment (Base line) | 64±20.03 | 62±21.18 | |||
| After Week 1 | 55.32±18.76 | 58.76±20.37 | P=0.028 | ||
| After Week 4 | 44.68±15.82 | 45.84±16.21 | P=0.607 | ||
| After Week 8 | 39.43±14.32 | 36.78±15.62 | P=0.357 | ||
| P-Value | Comparison between Base line VAS and after 1 weeks | P=0.000 | P=0.674 | ||
| Comparison between Base line VAS and after 4 & 8 weeks | P<0.05 | P<0.05 | |||
Abbreviations: DLX, Duloxetine; GBP, Gabapentin; VAS, Visual Analogue Scale.